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Angiomyolipoma of the kidney 
has classically been considered as 
a tumor of the connective tissue 
composed of fat, vascular tissue, 
and smooth muscle. In most cases, 
it is a tumor with benign behavior 
that may appear sporadically or 
associated with tuberous sclerosis 
syndrome. Macroscopically, these 
tumors are greyish yellow in color, 
and under an optical microscope, 
they are characterised by presenting 
the three components described. 
In recent years, several authors 
have published cases of epithelioid 
angiomyolipomas characterized 
by a minimal presence of fat 
in the tumor, positive for the 
melanoma-specific antigen, HMB-
45,(1) and on occasion, positive for 
desmin, melan-A, and others.(2,3)
Computed axial tomography and 
nuclear magnetic resonance studies 
hardly differentiate epithelioid 
angiomyolipomas from renal 
cell carcinoma.(3) We present a 
case of malignant epithelioid 
angiomyolipoma in a woman 
with no tuberous sclerosis, the 
debut of which was spontaneous 
retroperitoneal hemorrhage causing 
hypovolemic shock that required 
left radical nephrectomy. 
CASE REPORT
A woman aged 47 years old with 
no medical background of interest 
presented to the accident and 
emergency service complaining 
of sudden spontaneous pain 
in the left renal fossa and left 
abdomen, accompanied by nausea 
and vomiting. During clinical 
examination, blood pressure of 
120/65 mm Hg and a heart rate 
of 90 per minute were recorded, 
and the pain was localized in 
the left half of the abdomen and 
left renal fossa, with no signs of 
peritoneal irritation. On blood 
tests, hemoglobin was 9.5 g/dL; 
hematocrit, 29%; platelet count, 
230 × 109/L; and hematite, 3 
640 000/μL. Urine sediment was 
normal. The most significant 
finding of a single abdominal 
radiography was the lack of vision 
of the left psoas line. Treatment 
was begun with serum therapy, 
analgesia, and clinical observation.
One hour later, the patient 
presented arterial hypotension 
(90/50 mm Hg), tachycardia 
(130 per minute), peripheral 
hypoperfusion, and a generally 
poor condition, which was 
controlled by administering 
1000 mL of crystalloids. 
Abdominopelvic computed 
axial tomography revealed 
retroperitoneal hematoma from 
the left subdiaphragmatic region 
to the left pelvic region, with 
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morphological changes in the upper pole of the 
left kidney (Figure 1). A second blood test showed 
a decrease in the hematite count to 2 730 000/μL; 
hemoglobin, to 7 g/dL; and hematocrit, to 21%. 
Three hematite units were transfused.
Left lumbotomy was performed, extracting a 
large quantity of serohematic clots and liquid, 
with hemorrhage persisting from the upper half 
of the left kidney that could not be controlled, 
making it necessary to perform a pedicle ligature 
and left nephrectomy. Postoperatively, the 
patient progressed well. Control clinical studies 
revealed only an increase in the tumor marker 
CA125 (70.45 UI/mL; reference level, < 35 UI/
mL), with all other analytical parameters within 
the reference ranges (hematite count, 4100000/μL; 
hemoglobin, 13.4 g/dL; hematocrit, 37%; urea, 
25.4 mg/dL; creatinine, 0.8 mg/dL; and prolactin, 
22.9 ng/mL). 
Histology of the sample revealed that the tumor 
was composed of thick-walled smooth-muscled 
blood vessels, most notably in the perivascular 
areas, mixed with mature fatty tissue (Figure 2). 
Sandwiched between these two components, 
solid areas of large mononuclear or multinuclear 
areas were observed, with a pleomorphic 
hyperchromatic nucleus, prominent nucleolus, 
and abundant cytoplasm, clear in most cases, 
and eosinophilic in others. High atypical mitotic 
activity and necrotic areas were also seen, showing 
evident proliferative activity and malignance. 
Immunohistochemical study showed reactivity 
in the epithelioid cells for HMB-45, melan-A, and 
smooth-muscle actin and desmin, with a greatly 
Figure 1. A, Presence of hematoma in the left subdiaphragmatic region. B, Nodule of fatty density, 4 × 3 × 4.5 cm, at the upper pole of 
the left kidney, suggesting angiomyolipoma, with major perirenal hematoma displacing forward towards the pancreas, stomach, spleen, 
and left kidney. Hypodense image suggests cyst of the liver in segment 6. C, Retroperitoneal hematoma displacing left kidney and 
pancreas with circumaortic left kidney vein. D, Image of the same retroperitoneal hematoma extending towards the pelvis with free liquid 
in the Douglas space.
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increased cell proliferation index (Ki67).
Twelve months after the treatment, the patient 
was free of disease.
DISCUSSION
Owing to the difficulty of differential 
diagnosis of renal angiomyolipoma from other 
tumoral entities of the kidney, the HMB-45 
positivity in renal angiomyolipomas was first 
proposed in 1991, favoring its histological and 
immunohistochemical differentiation.(1) In 1947, 
Apitz described perivascular epithelioid cells 
for the first time as abnormal myoblasts inside 
angiomyolipomas.(4) Thereafter, these cells 
began to be described more accurately, proving 
positive for HMB-45, desmin, Melan-A, HMSA-1, 
and other markers, leading to the proposal 
of a new tumoral entity called perivascular 
epithelioid cell tumor (namely, PEComa).(5) The 
epithelioid variety of angiomyolipoma has been 
defined histologically as the presence of pure 
epithelioid cells with positive melanogenesis 
markers, without the presence of adipocytes 
or vascular tissue. However, some classical 
angiomyolipomas present epithelioid cells with 
an atypical component, a high proliferative index 
and focal necrosis indicating a malign tumoral 
process that may be considered as epithelioid 
angiomyolipoma.(5) Genetic studies have been 
performed confirming the existence of allelic 
disorders in chromosome 16p (gene TSC2), which 
may alter the route rev/mTOR/p70S6K and are 
present in PEComas and angiomyolipoma.(5,6) The 
expression of such growth factors as CD117 or, 
as in our case, Ki67 has been observed, as well as 
Figure 2. A, Staining by hematoxylin-eosin shows thick-walled blood vessels, smooth muscle, and mature fatty tissue with atypical 
cells of epithelioid appearance. B, Immunohistochemistry with reactivity for smooth-muscle actin. C, Immunohistochemistry with focal 
reactivity for HMB-45. D, Immunohistochemistry with focal reactivity for melan-A.
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disorders in the tumor-suppressant gene P53.(7,8)
In one published case, the presence of very high 
prolactin levels was seen, which returned to 
normal after the tumor was removed.(2)
It is far from easy to carry out an epithelioid 
angiomyolipoma diagnosis using imaging 
techniques, particularly when it comes to 
differentiating it from renal cell carcinoma. 
For this reason, radical nephrectomy is usually 
indicated after computed axial tomography or 
nuclear magnetic resonance studies. The main 
treatment applied in such patients is usually 
radical nephrectomy, with adjuvant therapy in 
these cases being the subject of some controversy, 
although these tumors have been described as 
being chemosensitive to doxorubicin, d-carbacin, 
ifosfamide, cyclophosphamide, and cisplatin.(3)
Cases have been described of metastasis extending 
into the liver, bone, and retroperitoneum either 
during diagnosis or after a period of monitoring,(9)
making it vitally important to establish a clear 
adjuvant therapy for this patient group.
The incidence of epithelioid angiomyolipoma 
is thought to be underestimated owing to the 
difficulties to date differentiating it in diagnosis 
from liver cell carcinoma, with many diagnoses 
given as liver cell carcinoma actually being 
epithelioid angiomyolipoma.(10) We consider the 
exploration of preoperative differential diagnosis 
of this pathology using imaging techniques, 
enabling us to apply a better therapeutic strategy. 
Great progress has been made in the histological 
and immunohistochemical fields, making it easier 
for us to arrive at microscopic diagnosis, although 
we still need further studies to allow the etiology 
and etiological factors involved, adjuvant therapy 
and short-term and long-term prognosis for these 
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